咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Effect of transcutaneous elect... 收藏

Effect of transcutaneous electroacupuncture at Neiguan(PC 6) on refractory vomiting in patients in intensive care unit

Effect of transcutaneous electroacupuncture at Neiguan(PC 6) on refractory vomiting in patients in intensive care unit

作     者:Benoit Bataille Carine Chan-Shun Bastian Nucci Bernard Verdoux Michel Mora Pierre Cocquet Stein Silva 

作者机构:Department of Intensive Care MedicineNarbonne HospitalNarbonne F-11100France Centre Hospitalier de NarbonneService de Réanimation PolyvalenteNarbonne F-11100France Department of Anesthesiology and Critical Care MedicinePurpan University HospitalToulouse F-31059France Department of Intensive Care VledicineNarbonne HospitalNarbonne F-11 1 00France 

出 版 物:《Journal of Traditional Chinese Medicine》 (中医杂志(英文版))

年 卷 期:2017年第37卷第4期

页      面:554-557页

核心收录:

学科分类:1007[医学-药学(可授医学、理学学位)] 1005[医学-中医学] 1002[医学-临床医学] 10[医学] 

主  题:Electroacupuncture 点 PC 6 (Neiguan ) 恶心 呕吐 Antiemetics 

摘      要:OBJECTIVE: To observe the effect of transcutaneous electroacupuncture(TEA) at Neiguan(PC 6) on refractory vomiting in critically ill patients in intensive care(ICU) ***: Ten patients admitted in ICU and presenting vomiting refractory to one or more antiemetic drugs were prospectively included in the study. TEA was applied at acupoint of Neiguan(PC6) during 30 min with a neuromuscular transmission monitor(single-twitch stimulation with 1 Hz at a constant current of 10 m A). Nausea and Vomiting were evaluated at the following intervals: immediately after 30 min of TEA at Neiguan(PC 6),30 min-6h and 6-24 h. The presence of nausea and/or vomiting throughout the observational period was defined as the primary end ***: The presence of nausea or vomiting throughout the observational period was 10% at the end of TEA, 40% between 30 min and 6 h, and50% between 30 min and 24 h(P 0.001, P = 0.01 and P = 0.03 vs pre-TEA, respectively). There were no complications or side effects related to ***: TEA at Neiguan(PC 6) seems effective in reducing refractory vomiting in the patients in ICU setting, even if larger trials are needed to define optimal modalities.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分